Published

Psychedelic Medicine for Mental Illness and Substance Use Disorders: Overcoming Social and Legal Obstacles

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: SSRN Electronic Journal
Date: 2017-11-02
Source: OpenAlex
DOI: Unavailable
PubMed: Unavailable

Authors

Mason Marks

Watch author

Derived topics and classifications

psilocybin Anxiety Addiction Mechanism of Action Creativity Review Article Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 0 indexed papers cite this DOI.

Open citation network

Related papers

Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)Journal of Clinical Medicine · 2026-08-12 Psychedelic Therapy for DepressionUnknown journal · 2026-08-11 Evaluating psilocybin for the management of depression: a literature reviewBritish Journal of Mental Health Nursing · 2026-08-02 Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin ServicesJAMA Network Open · 2026-08-19 Ayahuasca and Salvia divinorum as contrasting modes of consciousness reorganization: Implications for psychedelic-assisted psychotherapyJournal of Psychedelic Studies · 2026-08-13 Exploring Psychedelics as Novel Therapeutics for Smoking Cessation: Mechanistic Insights from Animal StudiesVCU Scholars Compass (Virginia Commonwealth University) · 2026-08-21 Advanced research eyes potential of psychedelics for complex casesMental Health Weekly · 2026-08-07 JAMA study examines Oregon's psilocybin services modelMental Health Weekly · 2026-08-24